These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 10235104)

  • 1. Further evidence suggesting a limited role of digitalis in infants with circulatory congestion secondary to large ventricular septal defect.
    Seguchi M; Nakazawa M; Momma K
    Am J Cardiol; 1999 May; 83(9):1408-11, A8. PubMed ID: 10235104
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The use of digitalis in heart failure.
    Rahimtoola SH; Tak T
    Curr Probl Cardiol; 1996 Dec; 21(12):781-853. PubMed ID: 8968683
    [No Abstract]   [Full Text] [Related]  

  • 3. Acute hemodynamic effects of dopamine, dobutamine, and isoproterenol in congested infants or young children with large ventricular septal defect.
    Nakazawa M; Takahashi Y; Aiba S; Okuda H; Ohta H; Takao A
    Jpn Circ J; 1987 Sep; 51(9):1010-5. PubMed ID: 3694764
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Circulatory failure in children with left-to-right shunt in the framework of congenital heart defects: pathophysiology and therapeutic results].
    Wessel A; Buchhorn R; Bürsch J
    Klin Padiatr; 2000; 212(2):53-9. PubMed ID: 10812553
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hemodynamic effects of hydralazine in infants with a large ventricular septal defect.
    Beekman RH; Rocchini AP; Rosenthal A
    Circulation; 1982 Mar; 65(3):523-8. PubMed ID: 6459891
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Denopamine augments the left ventricular pump function in infants with ventricular septal defect and pulmonary hypertension: Doppler echocardiographic analysis.
    Tomita H; Ikeda K; Chiba S
    Tohoku J Exp Med; 1994 Feb; 172(2):111-21. PubMed ID: 8073422
    [TBL] [Abstract][Full Text] [Related]  

  • 7. ["Natural history" and "unnatural history" of ventricular septal defect].
    Olariu-Ungureanu A; Socaciu A; Anastasiu M; Toderan V; Săvulescu M
    Rev Pediatr Obstet Ginecol Pediatr; 1979; 28(3):215-22. PubMed ID: 119990
    [No Abstract]   [Full Text] [Related]  

  • 8. Digitalis therapy for patients in clinical heart failure.
    Rahimtoola SH
    Circulation; 2004 Jun; 109(24):2942-6. PubMed ID: 15210610
    [No Abstract]   [Full Text] [Related]  

  • 9. [Treatment of heart failure: what--when--how?].
    Blömer H
    Verh Dtsch Ges Inn Med; 1990; 96():157-67. PubMed ID: 2092435
    [No Abstract]   [Full Text] [Related]  

  • 10. Digitalis pharmacology and therapeutics: recent advances.
    Mason DT
    Ann Intern Med; 1974 Apr; 80(4):520-30. PubMed ID: 4621264
    [No Abstract]   [Full Text] [Related]  

  • 11. Biochemical and physiologic response to isoproterenol in patients with left ventricular failure.
    Krasnow N
    Am J Cardiol; 1971 Jan; 27(1):73-81. PubMed ID: 5538715
    [No Abstract]   [Full Text] [Related]  

  • 12. Clinical Use of Digitalis: A State of the Art Review.
    Whayne TF
    Am J Cardiovasc Drugs; 2018 Dec; 18(6):427-440. PubMed ID: 30066080
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Positive inotropic substances in therapy of heart failure: digitalis, catecholamines, phosphodiesterase inhibitors].
    Stefenelli T
    Acta Med Austriaca; 1991; 18(4):81-5. PubMed ID: 1763582
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Digitalis Investigation Group (DIG) trial: a stimulus for further research.
    Gheorghiade M; Pitt B
    Am Heart J; 1997 Jul; 134(1):3-12. PubMed ID: 9266777
    [No Abstract]   [Full Text] [Related]  

  • 15. Digitalis--friend or foe?
    Erdmann E
    Eur Heart J; 1995 Jul; 16 Suppl F():16-9. PubMed ID: 8521879
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Acute hemodynamic effects of converting enzyme inhibition in children with intracardiac shunts.
    Webster MW; Neutze JM; Calder AL
    Pediatr Cardiol; 1992 Jul; 13(3):129-35. PubMed ID: 1318542
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A physiologic approach to the treatment of heart failure.
    Katz AM
    Hosp Pract (Off Ed); 1987 Feb; 22(2):117-21, 125-36, 141-2 passim. PubMed ID: 2433299
    [No Abstract]   [Full Text] [Related]  

  • 18. Long-term outcome of patients operated for large ventricular septal defects with increased pulmonary vascular resistance.
    Kannan BR; Sivasankaran S; Tharakan JA; Titus T; Ajith Kumar VK; Francis B; Krishnamoorthy KM; Harikrishnan S; Padmakumar R; Nair K
    Indian Heart J; 2003; 55(2):161-6. PubMed ID: 12921332
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nitroprusside abolishes the deleterious effects of surface cooling-induced hypothermia on immature pigs with ventricular septal defects.
    Gott JP; Cox S; Mavroudis C
    J Thorac Cardiovasc Surg; 1987 May; 93(5):647-57. PubMed ID: 3573778
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Afterload reduction treatment for large ventricular septal defects. Dependence of haemodynamic effects of hydralazine on pretreatment systemic blood flow.
    Nakazawa M; Takao A; Shimizu T; Chon Y
    Br Heart J; 1983 May; 49(5):461-5. PubMed ID: 6838733
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.